Brexpiprazole Microspheres for Injection(Hangzhou Heze Pharma)

注射用布瑞哌唑微球（珠海市丽珠微球科技）

Report date: 2026/03/26 20:00:17

Base Information

Drug NameBrexpiprazole Microspheres for Injection(Hangzhou Heze Pharma)

Drug Alias Namebrexpiprazol布瑞哌唑brexpiprazole依匹哌唑brexpiprazolum +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonists

TargetsSerotonin 2a (5-HT2a) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor

Therapy Area/IndicationsSchizophrenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSchizophrenia

Inactive IndicationsN/A

ATC CodeN/A